Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide

Atsushi Takahashi, Pascal Goldschmidt-Clermont, Emad S. Alnemri, Teresa Fernandes-Alnemri, Kumiko Yoshizawa-Kumagaya, Kiichiro Nakajima, Masataka Sasada, Guy G. Poirier, William C. Earnshaw

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Biochemical analyses of nuclear apoptosis in vitro have revealed the existence of multiple active interleukin-1β-converting enzyme-related proteases (caspases) with distinct substrate recognition properties in extracts of preapoptotic chicken DU249 cells (S/M extracts). Previously we demonstrated that the activity of a caspase that cleaves lamins is required for the disintegration of nuclei in the late stages of apoptosis, despite the presence of a second active caspase that cleaves poly(ADP-ribose) polymerase (PARP). One simple explanation for this observation was that the lamin-cleaving caspase is sufficient to drive the nuclear events of apoptotic execution. Here, we report that phenylarsine oxide (PAO) inhibits the protease activities of recombinant human caspases as well as endogenous chicken caspases that are active in S/M extracts. PAO at 100 μM blocks the morphological changes of nuclear apoptosis in vitro and internucleosomal DNA fragmentation in S/M extracts without interfering with PARP or lamin A cleavage. Thus, lamin cleavage is not sufficient to drive the changes in nuclear morphology characteristic of apoptosis. Affinity labeling with YV(bio)KD-aomk shows that the degree of sensitivity to PAO differs among active caspases in S/M extracts. These results suggest that a PAO-sensitive caspase that is distinct from the PARP- or lamin-cleaving enzymes is required for the initiation of apoptotic morphological changes and for the activation of endonuclease(s). Taken together, our results suggest that two or more caspases are required for proteolytic events that are essential for the initiation and completion of nuclear apoptotic changes. The observation that PAO is an inhibitor of caspases and nuclear apoptotic events should be useful for the biochemical dissection of apoptosis in vitro and in vivo.

Original languageEnglish
Pages (from-to)123-131
Number of pages9
JournalExperimental Cell Research
Volume231
Issue number1
DOIs
StatePublished - Feb 25 1997
Externally publishedYes

Fingerprint

Caspase 1
Caspases
Apoptosis
Lamins
Poly(ADP-ribose) Polymerases
Chickens
Peptide Hydrolases
Lamin Type A
oxophenylarsine
Caspase Inhibitors
Endonucleases
DNA Fragmentation
Human Activities
Dissection

ASJC Scopus subject areas

  • Cell Biology

Cite this

Takahashi, A., Goldschmidt-Clermont, P., Alnemri, E. S., Fernandes-Alnemri, T., Yoshizawa-Kumagaya, K., Nakajima, K., ... Earnshaw, W. C. (1997). Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. Experimental Cell Research, 231(1), 123-131. https://doi.org/10.1006/excr.1996.3459

Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. / Takahashi, Atsushi; Goldschmidt-Clermont, Pascal; Alnemri, Emad S.; Fernandes-Alnemri, Teresa; Yoshizawa-Kumagaya, Kumiko; Nakajima, Kiichiro; Sasada, Masataka; Poirier, Guy G.; Earnshaw, William C.

In: Experimental Cell Research, Vol. 231, No. 1, 25.02.1997, p. 123-131.

Research output: Contribution to journalArticle

Takahashi, A, Goldschmidt-Clermont, P, Alnemri, ES, Fernandes-Alnemri, T, Yoshizawa-Kumagaya, K, Nakajima, K, Sasada, M, Poirier, GG & Earnshaw, WC 1997, 'Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide', Experimental Cell Research, vol. 231, no. 1, pp. 123-131. https://doi.org/10.1006/excr.1996.3459
Takahashi A, Goldschmidt-Clermont P, Alnemri ES, Fernandes-Alnemri T, Yoshizawa-Kumagaya K, Nakajima K et al. Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. Experimental Cell Research. 1997 Feb 25;231(1):123-131. https://doi.org/10.1006/excr.1996.3459
Takahashi, Atsushi ; Goldschmidt-Clermont, Pascal ; Alnemri, Emad S. ; Fernandes-Alnemri, Teresa ; Yoshizawa-Kumagaya, Kumiko ; Nakajima, Kiichiro ; Sasada, Masataka ; Poirier, Guy G. ; Earnshaw, William C. / Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. In: Experimental Cell Research. 1997 ; Vol. 231, No. 1. pp. 123-131.
@article{38c9d77fa5c243f3a42efdf9795b209f,
title = "Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide",
abstract = "Biochemical analyses of nuclear apoptosis in vitro have revealed the existence of multiple active interleukin-1β-converting enzyme-related proteases (caspases) with distinct substrate recognition properties in extracts of preapoptotic chicken DU249 cells (S/M extracts). Previously we demonstrated that the activity of a caspase that cleaves lamins is required for the disintegration of nuclei in the late stages of apoptosis, despite the presence of a second active caspase that cleaves poly(ADP-ribose) polymerase (PARP). One simple explanation for this observation was that the lamin-cleaving caspase is sufficient to drive the nuclear events of apoptotic execution. Here, we report that phenylarsine oxide (PAO) inhibits the protease activities of recombinant human caspases as well as endogenous chicken caspases that are active in S/M extracts. PAO at 100 μM blocks the morphological changes of nuclear apoptosis in vitro and internucleosomal DNA fragmentation in S/M extracts without interfering with PARP or lamin A cleavage. Thus, lamin cleavage is not sufficient to drive the changes in nuclear morphology characteristic of apoptosis. Affinity labeling with YV(bio)KD-aomk shows that the degree of sensitivity to PAO differs among active caspases in S/M extracts. These results suggest that a PAO-sensitive caspase that is distinct from the PARP- or lamin-cleaving enzymes is required for the initiation of apoptotic morphological changes and for the activation of endonuclease(s). Taken together, our results suggest that two or more caspases are required for proteolytic events that are essential for the initiation and completion of nuclear apoptotic changes. The observation that PAO is an inhibitor of caspases and nuclear apoptotic events should be useful for the biochemical dissection of apoptosis in vitro and in vivo.",
author = "Atsushi Takahashi and Pascal Goldschmidt-Clermont and Alnemri, {Emad S.} and Teresa Fernandes-Alnemri and Kumiko Yoshizawa-Kumagaya and Kiichiro Nakajima and Masataka Sasada and Poirier, {Guy G.} and Earnshaw, {William C.}",
year = "1997",
month = "2",
day = "25",
doi = "10.1006/excr.1996.3459",
language = "English",
volume = "231",
pages = "123--131",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide

AU - Takahashi, Atsushi

AU - Goldschmidt-Clermont, Pascal

AU - Alnemri, Emad S.

AU - Fernandes-Alnemri, Teresa

AU - Yoshizawa-Kumagaya, Kumiko

AU - Nakajima, Kiichiro

AU - Sasada, Masataka

AU - Poirier, Guy G.

AU - Earnshaw, William C.

PY - 1997/2/25

Y1 - 1997/2/25

N2 - Biochemical analyses of nuclear apoptosis in vitro have revealed the existence of multiple active interleukin-1β-converting enzyme-related proteases (caspases) with distinct substrate recognition properties in extracts of preapoptotic chicken DU249 cells (S/M extracts). Previously we demonstrated that the activity of a caspase that cleaves lamins is required for the disintegration of nuclei in the late stages of apoptosis, despite the presence of a second active caspase that cleaves poly(ADP-ribose) polymerase (PARP). One simple explanation for this observation was that the lamin-cleaving caspase is sufficient to drive the nuclear events of apoptotic execution. Here, we report that phenylarsine oxide (PAO) inhibits the protease activities of recombinant human caspases as well as endogenous chicken caspases that are active in S/M extracts. PAO at 100 μM blocks the morphological changes of nuclear apoptosis in vitro and internucleosomal DNA fragmentation in S/M extracts without interfering with PARP or lamin A cleavage. Thus, lamin cleavage is not sufficient to drive the changes in nuclear morphology characteristic of apoptosis. Affinity labeling with YV(bio)KD-aomk shows that the degree of sensitivity to PAO differs among active caspases in S/M extracts. These results suggest that a PAO-sensitive caspase that is distinct from the PARP- or lamin-cleaving enzymes is required for the initiation of apoptotic morphological changes and for the activation of endonuclease(s). Taken together, our results suggest that two or more caspases are required for proteolytic events that are essential for the initiation and completion of nuclear apoptotic changes. The observation that PAO is an inhibitor of caspases and nuclear apoptotic events should be useful for the biochemical dissection of apoptosis in vitro and in vivo.

AB - Biochemical analyses of nuclear apoptosis in vitro have revealed the existence of multiple active interleukin-1β-converting enzyme-related proteases (caspases) with distinct substrate recognition properties in extracts of preapoptotic chicken DU249 cells (S/M extracts). Previously we demonstrated that the activity of a caspase that cleaves lamins is required for the disintegration of nuclei in the late stages of apoptosis, despite the presence of a second active caspase that cleaves poly(ADP-ribose) polymerase (PARP). One simple explanation for this observation was that the lamin-cleaving caspase is sufficient to drive the nuclear events of apoptotic execution. Here, we report that phenylarsine oxide (PAO) inhibits the protease activities of recombinant human caspases as well as endogenous chicken caspases that are active in S/M extracts. PAO at 100 μM blocks the morphological changes of nuclear apoptosis in vitro and internucleosomal DNA fragmentation in S/M extracts without interfering with PARP or lamin A cleavage. Thus, lamin cleavage is not sufficient to drive the changes in nuclear morphology characteristic of apoptosis. Affinity labeling with YV(bio)KD-aomk shows that the degree of sensitivity to PAO differs among active caspases in S/M extracts. These results suggest that a PAO-sensitive caspase that is distinct from the PARP- or lamin-cleaving enzymes is required for the initiation of apoptotic morphological changes and for the activation of endonuclease(s). Taken together, our results suggest that two or more caspases are required for proteolytic events that are essential for the initiation and completion of nuclear apoptotic changes. The observation that PAO is an inhibitor of caspases and nuclear apoptotic events should be useful for the biochemical dissection of apoptosis in vitro and in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0031585860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031585860&partnerID=8YFLogxK

U2 - 10.1006/excr.1996.3459

DO - 10.1006/excr.1996.3459

M3 - Article

C2 - 9056419

AN - SCOPUS:0031585860

VL - 231

SP - 123

EP - 131

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 1

ER -